Progenics Pharmaceuticals Inc (PGNX)

Trade PGNX now with
8/5/2019 8:36:34 AM Progenics Pharma Completes Enrollment In Pivotal Phase 3 CONDOR Study Of PyL For Detection Of Prostate Cancer
7/22/2019 8:17:30 AM Velan : Voting Results At Progenics Confirm Two-Thirds Of Votes Cast Against Re-Election Of Peter Crowley And Michael
7/12/2019 9:36:38 AM Progenics Begins Search Process To Identify New Board Candidates
7/8/2019 8:35:26 AM Progenics Urges Shareholders To Vote Today “FOR” The Highly Qualified Director Candidates On The WHITE Proxy Card
7/8/2019 8:04:59 AM Velan Reminds Stockholders To Follow ISS' Recommendation By Voting "Against" Progenics Directors Crowley And Kishbauch
7/8/2019 7:35:35 AM Progenics Appoints Huw Jones To Newly Created Role Of VP, Commercial
7/1/2019 8:03:42 AM Velan Urges Stockholders To Vote "Against" Progenics Directors Peter Crowley And Michael Kishbauch
6/28/2019 12:11:27 AM Velan Clarifies Interactions With Progenics Pharma' Board Of Directors
6/20/2019 8:33:43 AM Progenics Pharma To Initiate Basket Trial By Year End To Support An Expanded Label For AZEDRA
6/20/2019 7:40:37 AM Velan Capital Calls On Progenics' Board To Back Up Recent Claims
6/19/2019 8:40:39 AM Progenics Urges Shareholders To Vote “For” All Of Company’s Directors On The WHITE Proxy Card
6/13/2019 8:43:08 AM Progenics Doses First Patient In Phase 2 Clinical Study Of 1095 Radiotherapy
1/3/2019 1:31:32 AM Progenics And Curium Announce European Collaboration For Prostate Cancer Imaging Agent PyL
11/8/2018 7:42:35 AM Progenics Pharma Q3 Net Loss $24.4 Mln Or $0.30/Shr Vs Loss Of $15.4 Mln Or $0.22/Shr Last Year
10/5/2018 7:32:30 AM Progenics Announces Data From Its OSPREY 2301 Study Of PyL
9/17/2018 6:03:40 AM Progenics Adds AZEDRA To National Comprehensive Cancer Network Guidelines For Pheochromocytoma And Paraganglioma